Scientists unveil breakthrough treatment that cuts bad cholesterol by 50%

Bad cholesterol can majorly affect your health and sometimes lead to heart attacks and strokes, which can be fatal.

Scientists introduce a new breakthrough method to reduce bad cholesterol. Early results show major drops in cholesterol levels without the typical side effects of standard medications.

Bad cholesterol side effects:

Bad cholesterol, or low-density lipoprotein LDL is a waxy substance that transports cholesterol to cells, through which excess levels build up in artery walls, restricting blood flow and drastically increasing the risk of heart attacks and strokes.

A new DNA based treatment blocks a key protein that keeps bad cholesterol high, helping the body clear it more effectively.

High levels of bad cholesterol in the bloodstream can lead to hypercholesterolemia, a condition that damages arteries and raises the risk of heart disease, therefore the new treatment promises to cut bad cholesterol by nearly 50%, which could contribute to great relief for doctors.

Researchers from the University of Barcelona and the University of Oregon have developed a promising new approach to control cholesterol levels, offering a potential new way to combat atherosclerosis, which occurs when fatty plaques build up in artery walls.

Treatment for Bad Cholesterol:

Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key protein that keeps “bad” LDL cholesterol circulating in the blood.

By blocking this protein, cells can absorb more cholesterol instead of letting it build up in arteries, dramatically lowering levels linked to heart disease.

The research team focused on a new tyoe of protein that plays a central role in regulating levels of low-density lipoprotein cholesterol LDL, often called "bad" cholesterol.

They designed a method to block the production of this protein using specialized DNA-based molecules known as "polypurine hairpins PPRH."

By suppressing PCSK9, the treatment helps cells absorb more cholesterol, reducing the amount circulating in the blood and limiting buildup in the arteries.

The researchers tested the therapy in laboratory-grown liver cells and in transgenic mice that carry the human gene.

The findings were originally published in the journal Biochemical Pharmacology.

If confirmed in further studies, this new strategy could provide a safer and more targeted way to lower cholesterol and reduce the risk of heart disease and change how high cholesterol is treated, offering a powerful alternative to traditional drugs.